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Intraspinal quisqualic acid (QUIS) injury induce (i) mechanical and thermal hyperalgesia, (ii)
progressive self-injurious overgrooming of the affected dermatome. The latter is thought
to resemble painful dysesthesia observed in spinal cord injury (SCI) patients. We have
reported previously loss of endogenous GABA immunoreactive (IR) cells in the superﬁ-
cial dorsal horn of QUIS rats 2 weeks post injury. Further histological evaluation showed
that GABA-, glycine-, and synaptic vesicular transporter VIAAT-IR persisted but were sub-
stantially decreased in the injured spinal cord. In this study, partially differentiated GABA-IR
embryonic neural precursor cells (NPCs) were transplanted into the spinal cord of QUIS rats
to reverse overgrooming by replenishing lost inhibitory circuitry. Rat E14 NPCs were predif-
ferentiated in 0.1 ng/ml FGF-2 for 4 h prior to transplantation. In vitro immunocytochemistry
of transplant cohort showed large population of GABA-IR NPCs that double labeled with
nestin but few colocalized with NeuN, indicating partial maturation. Two weeks following
QUIS lesion at T12-L1, and following the onset of overgrooming, NPCs were transplanted
into the QUIS lesion sites; bovine adrenal ﬁbroblast cells were used as control. Overgroom-
ing was reduced in>55.5% of NPC grafted animals, with inverse relationship between the
number of surviving GABA-IR cells and the size of overgrooming. Fibroblast-control ani-
mals showed a progressive worsening of overgrooming. At 3 weeks post-transplantation,
numerous GABA-, nestin-, and GFAP-IR cells were present in the lesion site. Surviving
grafted GABA-IR NPCs were NeuN+ and GFAP−.These results indicate that partially differ-
entiated NPCs survive and differentiate in vivo into neuronal cells following transplantation
into an injured spinal cord. GABA-IR NPC transplants can restore lost dorsal horn inhibitory
signaling and are useful in alleviating central pain following SCI.
Keywords: cortical progenitor cell, quisqualic acid, spinal cord injury, GABA, transplantation, neuropathic pain,
VIAAT, overgrooming
INTRODUCTION
Pain is a major complication in patients with spinal cord injury
(SCI) where conventional pharmacological, electrical, or psy-
chological treatments provide only minor and temporary relief
(Finnerup et al., 2002; Finnerup and Jensen, 2004; Widerstrom-
Noga et al., 2008; Siddall, 2009; Kwon et al., 2010; Mann et al.,
2010). Mechanisms involved in the establishment of SCI pain are
still not fully understood due to difﬁculties in dissociating trau-
matic cascade of events occurring in the spinal cord to those arising
from the dorsal root ganglia, sympathetic ganglia, and peripheral
nerves (O’Brien et al., 1994; Bethea et al., 1998; Miranda et al.,
1999; Springer et al., 1999; Yaksh et al., 1999; Saito et al., 2000;
Bruce et al., 2002; Hains et al., 2003b; Hoheisel et al., 2003). Fur-
thermore, biochemical events leading to abnormal ﬁring of spinal
neurons (Mills et al., 2001; Yezierski et al., 2004), up-regulation of
voltage-gated ion channels (Nashmi and Fehlings, 2001; Edwards
et al., 2002; Hains et al., 2003a), recruitment of reactive glia
(Carlton et al., 2009), and excessive release of excitatory amino
acids (excitotoxicity) in the spinal gray and white matters add to
the complexity of neuropathic pain in SCI patients (Mills et al.,
2001; Zeilig et al., 2012).
Excitotoxicity-induced SCI model using intraspinal injec-
tions of the AMPA- and metabotropic glutamate receptor ago-
nist quisqualic acid (QUIS) have been described by Yezierski
et al. (Yezierski et al., 1993, 1998; Gorman et al., 2001). QUIS
can produce more controlled-lesion with characteristic neu-
ronal loss, demyelination, cavitation, glial activation, perivascular
changes, breakdown of the blood-brain barrier, and inﬂamma-
tion, closely mimicking sequence of events observed in contu-
sion or ischemic injured spinal cords. QUIS injured rats exhibit
nociceptive behaviors for mechanical and cold allodynia and self-
injurious overgrooming behaviors (Brewer and Yezierski, 1998;
Gorman et al., 2001). Overgrooming behavior is thought to be
mediated by dysesthetic sensations originating from the affected
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at-level dermatomes and/or DRGs ipsilateral to insult (Brewer
et al., 2008), and disruption of inhibitory tone maintained by
endogenous GABAergic neurons in the superﬁcial dorsal horn
(Lee et al., 2008). QUIS injury also up-regulates ERK1/2, TNF-α,
and cytokines known to be involved inmolecular events leading to
development of nociception (Yu and Yezierski, 2005; Brewer and
Nolan, 2007).
Loss of endogenous GABA-IR cells following QUIS or
CNS/PNS injuries may play an important function in modulat-
ing nociception (Zhang et al., 1994; Lee et al., 2008), yet their
role remains elusive (Polgar et al., 2003; Polgar and Todd, 2008).
Chronic constriction injury in rats induce increased number of
picnotic cells, hyperchromatic “dark neurons” possibly indica-
tive of transsynaptic degeneration in the superﬁcial spinal or
medullary dorsal horn, in the superﬁcial dorsal horn by one week
post injury (Ibuki et al., 1997), and spared nerve injury decreases
primary afferent-induced IPSCs in lamina II neurons, presum-
ably due to the loss of GABA resulting from decreased GAD
65 expression (Moore et al., 2002). Such injury-induced noci-
ceptive behaviors can be further exacerbated by pharmacologic
blockade of inhibitory neurotransmission (Sugimoto et al., 1987,
1990; Hama and Sagen, 1993). In stereological estimates from EM
sections, excitotoxic neuronal cell death in the superﬁcial dorsal
horn was also observed in sciatic nerve-lesioned animals following
stimulation of A ﬁbers (Coggeshall et al., 2001), and cell death in
the superﬁcial dorsal horn (TUNEL labeling) has been observed
following CCI and sciatic neurectomy which could be prevented
by NMDA antagonists and caspase inhibitors (Azkue et al., 1998;
Whiteside and Munglani, 2001; Scholz et al., 2005). Nerve injury-
induced nociceptive behaviors can be reversed by the administra-
tion of GABA into the spinal cord (Eaton et al., 1999a; Sokal and
Chapman, 2003). Intrathecal administration of baclofen or mus-
cimol, GABA receptor agonists, cause dose-dependent analgesia
in animals with peripheral nerve injury (Hwang andYaksh, 1997),
and these effects were blocked with the administration of GABA
receptor antagonist bicuculline suggesting speciﬁcity of GABA on
reducing noxious sensation (Malan et al., 2002).
Recently, several reports showed possible therapeutic use of
transplanting embryonic neural cells to control central and
peripheral nociceptive behaviors. Intraspinal transplantation of
mouse embryonic neural stem (ES) cells can reverse QUIS-
induced formalin and mechanical nociception (Hendricks et al.,
2006). Intraspinal and intrathecal injections of predifferentiated
GABAergic embryonic ES cells (human and rodent-derived) can
also reverse CCI/SNL-induced nociceptive behaviors (Mukhida
et al., 2007; Jergova et al., 2012), possibly by rescuing the endoge-
nous inhibitory neural circuitry (Vaysse et al., 2011). GABAergic
neuronal stem cells (hSSC, hNT, and mouse ES) have been used
to control pain arising from ischemic paraplegia as well as spinal
hemisection-induced nociception (Marsala et al., 2004; Cizkova
et al., 2007; Kim et al., 2010). Although it is not clear how the
embryonic cells achieve anti-nociception (via local secretion of
GABA or rescuing of endogenous GABAergic/inhibitory mecha-
nisms), transplantation of predifferentiated embryonic inhibitory
neurons can modulate nerve injury-induced pain. The source of
embryonic stem cells also may be of importance, as forebrain-
derived cells are reported to yield much higher density of
GABAergic cells than spinal cord-derived cells (Watanabe et al.,
2004).
The present study examined effects of transplanting partially
differentiated GABA-immunoreactive embryonic cortical precur-
sor cells in quisqualic acid-lesioned rat spinal cord to reverse
pain behavior. First, we looked at the pre-differentiation of cul-
tured embryonic rat cortical neurospheres into GABAergic phe-
notype by exposing the neurospheres to varying concentrations
of FGF-2. The second part of the experiment focused on trans-
plantation of predifferentiated GABAergic neurospheres into the
spinal cord of QUIS-lesioned animals for the alleviation of cen-
tral pain, indirectly measured by changes in overgrooming area.
Results of these experiments show transplantation of predifferen-
tiated GABAergic neural precursor cells (NPCs) into the spinal
cord of QUIS-lesioned animals prevents or reduces overgrooming
behavior. Portions of this work have been presented previously in
abstract form (Lee et al., 2001).
MATERIALS AND METHODS
ANIMALS
Male Sprague Dawley rats (220–250 g, Charles River labs) were
housed in a regular light condition (12:12 light and dark cycle)
with food and water ad libitum. All experimental procedures were
approved by the Institutional Animal Care and Use Committee
(IACUC) of the University of Miami, Miller School of Medicine.
QUISQUALIC ACID LESION
All animals in the study received quisqualic acid lesion (QUIS,
125mM, Sigma) at T12-L1 spinal level. QUIS was diluted in dis-
tilled water and aliquoted into 50μl/vial and kept frozen (−20˚C)
until use. Animals were anesthetized using 3% isoﬂurane/O2 and
a midline dorsal skin incision was made to expose the thoraco-
lumbar vertebrae. Laminectomy was performed to expose the
spinal T12-L1 levels. Animals were placed on a spinal stereotaxic
unit (David Kopf Inc., CA, USA), and dura was cut and retracted
laterally to expose the dorsal root entry zones. QUIS was injected
into the dorsal horn halfway between the dorsal vein and the dorsal
root entry zone using a glass micropipette attached to a Hamil-
ton syringe (10μl, Reno, NV, USA). Using a microinjector, three
injections of 0.4μl each of QUIS was injected into the spinal cord
gray matter at a depth of 1mm. Injections were made unilaterally
and spaced out at 500μm rostro-caudal direction (Figures 1B,C).
Upon completion of each QUIS injection, the glass pipette was left
in place for 60 s to prevent backﬂow. Muscle was closed to cover
the injection site and the skin was closed with the wound clips.
OVERGROOMING BEHAVIOR AND OVERGROOMING AREA
MEASUREMENTS
Tomeasure changes in pain threshold before and after predifferen-
tiated embryonic cell transplantation, the total skin overgrooming
area of each animal was digitally photographed (Figure 1C) and
thenmanually recorded by tracing the wound outline onto a semi-
transparent plastic ﬁlm superimposed over the overgrooming site.
The outlines on the ﬁlm were digitally retraced with Neurolu-
cida (MicroBrightField Inc., Williston, VT, USA) and the total
overgrooming area was obtained. For each QUIS-lesioned animal,
the total overgrooming area was measured in square millimeter
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FIGURE 1 | Overgrooming lesions were primarily observed on at-level
ipsilateral dermatomes two weeks after lesion [(A): black arrow]. (B) A
3D model of spinal cord showing three injections of approximate 1mm in
depth from the dorsal surface needed to induce overgrooming in QUIS
animals. (C) Characteristic loss of spinal neurons (Neu-N immunoreactivity)
in the neck of dorsal horn 2 weeks after QUIS injection (white arrow).
Neurons from the superﬁcial lamina I and II are mostly spared from the
excitotoxic cell death.
before transplantation (2 weeks post-lesion) and every week since
transplantation for 3 weeks up until the time of perfusion.
ISOLATION OF NEURAL PROGENITOR CELLS
Embryonic cortical neural progenitor cells were isolated from
E14 Sprague Dawley rats. Pregnant rats were deeply anesthetized
with an overdose of nembutal (Sodium pentobarbital, Abbott,
MI, USA) and a midline ventral incision was made to expose
the embryos. Lateral ganglionic eminence were dissected out and
placed into a 15ml conical tube containing cold Hank’s balanced
salt solution (HBSS, pH 7.2; Gibco). Isolated cortical tissues were
gently triturated mechanically to dissociate into single cells, resus-
pended and plated at low density (3.5× 106 in 7ml of media) in
N2 growth media (DMEM/F12+N2 supplement, pH 7.2; Gibco)
containing standard concentration of FGF-2 (10 ng/ml, R&D) at
37˚C. Embryonic precursor cells were grown as small neurospheres
and passaged by high ﬂow rate trituration every 3–4 days to main-
tain initial density. The N2 growth media was changed every 2
days, and additional 6μl FGF-2 (10 ng/ml) was added into the
media in between media changing days.
IN VITRO PARTIAL DIFFERENTIATION OF RAT EMBRYONIC CORTICAL
PRECURSOR CELLS INTO GABA-IMMUNOREACTIVE CELL TYPE
Five to ten days old cultured neurospheres were transferred to
15ml tubes, centrifuged at 700 RPM for 5min at 4˚C, and resus-
pended in N2 culture media containing either 0.1, 1, or 10 ng/ml
FGF-2. Neurospheres were incubated in these media for 4–16 h.
Neurospheres were then resuspended in N2 culture media with
10 ng/ml FGF-2 maintaining the initial density of approximately
0.5× 106 neurospheres/ml. Neurospheres were plated on a poly-
l-ornithine/ﬁbronectin (Sigma Aldrich) coated plastic plates for 1
day andﬁxedwith 4%paraformaldehyde to quantitate the number
of precursor cells differentiated into GABAergic cells in vitro after
exposure to different concentrations of FGF-2. Fixed cellswere also
processed for GABA, NeuN, nestin, GFAP, MAP-2, β-III-tubulin,
and BrdU immunoﬂuorescence.
IN VITRO QUANTITATION OF GABA CONCENTRATION SECRETED BY
THE EMBRYONIC PRECURSOR NEUROSPHERES
The growth media of cell culture from original harvested cells
(P0) and in vitro differentiated neurospheres (P1) were sampled
to ascertain the concentration of GABA secreted by the precursor
neurosphere cells. The neurospheres were not stimulated electri-
cally/physically in any way to induce GABA secretion. Twenty
microliters of growth media from both samples were collected
every day for 7 days. The passage 0 cells survived up to 4 days post
harvest whereas the passage 1 neurospheres were visibly healthy
even at 12 days post harvest. High-Pressure Liquid Chromatog-
raphy (HPLC) was used to measure the concentration of GABA
present in 20μl growthmedia sample. Samples were analyzed on a
chromatograph consisting of a BeckmanModel 118 Solvent Mod-
ule, a Beckman System Gold data system and an ESA Coulochem
II electrochemical detector. A 150-mm long, 3-mm-diameter ESA
C18 column was used. The mobile phase consisted of 1.5mM
sodiumoctane sulfonic acid,75mMNaH2PO4, triethylamine,and
10% acetonitrile dissolved in water at pH 3.0.
TRANSPLANTATION OF PREDIFFERENTIATED
GABA-IMMUNOREACTIVE EMBRYONIC PRECURSOR CELLS OR
CONTROL BOVINE FIBROBLAST CELLS IN QUIS RATS
Only rats exhibiting overgrooming behavior 10–14 days post-
QUIS lesion received cell transplantation (n = 34). Animals were
anesthetized and laminectomywas performed to expose the spinal
level where the QUIS lesion was made (T12-L1). Using glass
micropipette, three injections of 4μl each of neural progenitor
cells (50,000 cell/μl, total 600,000 cells/animal) were injected into
the dorsal horn, ipsilateral to QUIS lesion, at a depth of 0.5mm to
1mm (n = 27). Controls were injected with bovine ﬁbroblast cells
(n = 7). Glass pipette was left in place for 60 s to prevent backﬂow
of the cells, muscle was closed to cover the injection site, and the
skin was closed with wound clips. Rats were immunosuppressed
by cyclosporine A (i.p., 10mg/kg; Bedford Labs, OH, USA) from
−1 day until sacriﬁce.
IN VITRO AND SPINAL CORD IMMUNOHISTOCHEMISTRY
Three weeks after cell transplantation, and after weekly measure-
ments of overgrooming area, animals were anesthetized with an
overdose of pentobarbital and perfused transcardially using a
peristaltic pump. Animals were perfused with cold 0.9% saline
followed by either cold 4% paraformaldehyde in 0.1M phosphate
buffer (PB, pH 7.2) or 4% paraformaldehyde plus 1% glutaralde-
hyde in 0.1M PB. Spinal cords were removed and post-ﬁxed in the
same ﬁxative overnight, then placed in 30% sucrose-PB solution
for cryoprotection.
Predifferentiatedneurospheres (in vitro) andNPC-transplanted
QUIS spinal cords were processed for immunohistochemical
analysis. The neurospheres (5–7 days old) were ﬁxed with cold 4%
paraformaldehyde in Phosphate Buffered saline (PBS; pH 7.4),
and were incubated overnight in PBS with 0.4% Triton-X 100
and 5% normal goat serum (PBS-TGS) containing the following
primary antibodies: NeuN (1:300, mouse, Chemicon, MA, USA),
GABA (1:200, guinea pig, Protos Inc., NY, USA), GFAP (1:200,
mouse, Steinberg), nestin (1:10, mouse, rat401, Developmental
Studies Hybridoma Bank, Iowa City, IA, USA), and β-III-tubulin
(1:200, mouse, Chemicon, MA, USA). Depending on the dou-
ble labeling schedule, cells were incubated with species-speciﬁc
secondary antibodies conjugated with either AlexaFluor 488 or
AlexFluor 594 (Molecular Probes, NY; 1:200 in PBS-TGS) for 2 h
at room temperature. For BrdU labeling, ﬁxed neurospheres were
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treated with 2N HCl for 10min, washed in PBS and incubated in
Borate solution for 10min. After wash, cells were incubated in the
blocking solution, primary and secondary antibody according to
the protocol above. Some neurospheres were processed for GABA
immunostaining using biotinylated secondary antibody, followed
by incubation in avidin-biotin solution in PBS for 1h and using
DAB as a chromogen.
Spinal cord segments thoracic 10 to lumbar 5 were cut at
30μmusing a freezing microtome (American Optical,MA,USA),
rinsed in PBS, and then treated for 1 h at room temperature in
PBS-TGS. Sections were incubated overnight in PBS-TGS con-
taining the following primary antibodies: NeuN, GABA, GFAP,
nestin, and β-III-tubulin as described above. Spinal sections were
washed 3× 10min in cold PBS-TGS and incubated with species-
speciﬁc secondary antibodies conjugated with either AlexaFluor
488 or AlexFluor 594 for 2 h at room temperature. Some spinal
sections perfused with 4% paraformaldehyde-1% glutaraldehyde
were treated with 1% sodium borohydride in PBS (pH 7.4) for
20min at room temperature to mitigate background ﬂuorescence.
These sections were treated with PBS-TGS as above, and incu-
bated overnight at 4˚C in PBS-TGS containing combinations of
the following primary antibodies: anti-GABA (1:500, guinea pig,
Chemicon, MA, USA), anti-glycine (1:300, rabbit, Chemicon),
anti-vesicular inhibitory amino acid transporter (VIAAT; 1:200,
rabbit, gift from Dr. Bruno Gasnier, INSERM, Strasbourg-Cedex,
France), and anti-synaptobrevin (1:1000, mouse, Synaptic Sys-
tems, Gottingen, Germany). Sections were washed 3× 10min in
cold PBS-TGS, incubated at room temperature for 1 h in sec-
ondary antibodies: anti-guinea pig Alexa Fluor 488, anti-rabbit
Alexa Fluor 594, and anti-mouse Alexa Fluor 680. All ﬂuorescently
labeled sections were washed three times in PBS, mounted on
lysine-coated slides, air-dried and coverslipped using Vectashield
mounting media containing DAPI (Vector Lab, CA, USA).
MICROSCOPE AND IMAGE CAPTURING
Themajority of ﬂuorescent sectionswere visualizedwith anOlym-
pus ﬂuorescent microscope. Images were acquired with a color
CCD camera and ImagePro plus software (Media cybernetics
Inc., Silver Spring, MD, USA) on an Apple Macintosh computer.
Glutaraldehyde-treated, double- and triple-labeled sections were
imaged on a Carl Zeiss LSM 510 confocal microscopy setup. An
Axiovert 100M microscope with a motorized stage was operated
using a PC running Zeiss LSM software version 3.2. Fluorescence
was excited using Argon (514 nm) and HeNe (543, 633 nm) lasers
(Lasos Lasertechnik; Jena, Germany). Images stacks were acquired
with 10×dry and40×oil immersionmagniﬁcation (4 and43opti-
cal slices, respectively), and ﬂattened into planar images. Adobe
Photoshop was used as a digital layout tool for composition and
overlay of acquired images.
STEREOLOGICAL ANALYSIS
For the estimation of GABAergic and NeuN positive proﬁles
within the transplant area in QUIS-injected animals, serial
immunostained sections of lumbar spinal cord were analyzed
with Neurolucida (MicroBrightField Inc., Williston, VT, USA).
The transplant site was identiﬁed under 20× magniﬁcations.
Cells were counted within 0.015mm2 frame positioned over the
transplant area at 60×magniﬁcation. Stereological estimationwas
performed in 25–30 sections/spinal cord. Results are presented at
average± SEM.
STATISTICAL ANALYSIS
To analyze the overgrooming area of animals transplanted with
control ﬁbroblast cells and GABAergic precursor cells, the data
were analyzed by two-way ANOVA with repetitive measurements
with group and time post-transplantation as variables followed by
Holm–Sidak post hoc analysis; level of signiﬁcance was p< 0.05.
RESULTS
Approximately 30% of animals that received quisqualic acid lesion
in the spinal cord but did not display overgrooming behavior
within two weeks post injury were discarded from the study. In
general, overgrooming behavior was conﬁned to ipsilateral at-level
dermatomes, but a few animals displayed bilateral overgrooming
behavior (Figure 1A).
SPINAL CORD HISTOLOGY FOLLOWING QUIS LESION
In the present experiment, micro-injections of 1.2μl of QUIS
(total volume; 125mM) at a depth of 1mm from the dorsal surface
of the spinal cord (Figure 1B) was sufﬁcient to eliminate ipsilateral
spinal neurons at the neck of the dorsal horn from laminae III to
V/VI (Figure 1C). The lesion caused collapse of the gray matter
into a thin dorso-ventral neuropil. Most neurons in the superﬁcial
laminae I and II,however,were spared from the injury even 3weeks
after QUIS lesion and a large number of NeuN-immunoreactive
(NeuN-IR) cells were observed with a minimal gray matter dis-
ruption as previously reported (Lee et al., 2008). In almost all
cases, neuronal cell losses were conﬁned only to the dorsal gray
matter ipsilateral to lesion. In a few animals, there were cell losses
in the ipsilateral ventral horn and to the contralateral gray matter
due to the spread of QUIS across the central canal, and in some
instances, small cavitations in the spinal cord were observed in the
ipsilateral lesioned gray matter (Yezierski et al., 1993). These cases
were minor and may have been due to the age/weight of animal or
proximal to medial placement of the glass pipette tip at the time
of QUIS lesion.
CHANGES IN GABA, GLYCINE, AND VIAAT FOLLOWING QUIS LESION
Two weeks after QUIS lesion, there appeared substantially fewer
number of endogenous GABA-IR in the superﬁcial laminae I and
II (Figure 2B) as described previously (Lee et al., 2008). Such
a loss was speciﬁc to spinal level within the QUIS injury, since
endogenous GABA-IR in the contralateral side and spinal lev-
els outside the QUIS lesion area were not affected (Figure 2A).
Immunostaining for a broader panel of markers for inhibitory
neuronal signaling machinery revealed additional injury-induced
histological changes. The other major spinal cord inhibitory neu-
rotransmitter, glycine, was decreased in injured gray matter and in
spared superﬁcial laminae (Figure 2D), but remained unchanged
in the contralateral side (Figure 2C).
Immunostaining for synaptobrevin was used to mark synap-
tic vesicles in the spinal cord. Colocalization of synaptobrevin,
GABA, and VIAAT was detected in spinal cord dorsal horns as
white punctate staining (Figures 2E–F). Triple-labeled puncta
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FIGURE 2 | Decreased immunoreactivity for inhibitory signaling
components in injured spinal cord gray matter. Spinal cord sections
were stained for GABA (A,B) and glycine (C,D). Uninjured dorsal horns
showed robust staining for both neurotransmitters (A,C), but staining was
decreased in injured dorsal horns (B,D). Spinal cord sections were also
triple-stained for GABA, VIAAT, and synaptobrevin. A region within the
uninjured dorsal horn was enlarged (E), showing extensive VIAAT labeling
(arrowheads), few lone GABA puncta (arrows), and numerous triple-labeled
white puncta (block arrows). Enlargement of injured dorsal horn (F)
revealed substantially decreased VIAAT, abundant free GABA, and few
triple-labeled puncta. Scale bars= 200μm (D); 50μm (F).
were abundant in dorsal horns contralateral to QUIS injection,
particularly in superﬁcial laminae (Figure 2E).QUIS-injecteddor-
sal horns appear to exhibit reduced triple labeling of inhibitory
synaptic vesicle markers (Figure 2F). The VIAAT-IR was abun-
dant in gray matter contralateral to QUIS injection (Figure 2E)
but substantially decreased in the ipsilateral dorsal horn afterQUIS
(Figure 2F) which suggest that inhibitory synaptic vesicles may be
depleted in the injured dorsal horn.
TIME COURSE OF CHANGES IN GABA IMMUNOREACTIVITY FROM
ISOLATED EMBRYONIC CORTICAL PRECURSOR CELLS
Under standard growth condition with constant 10 ng/ml FGF-
2/N2 culture media, the proportion of GABA-IR cells found in
freshly isolated primary cortical embryonic tissues was minimal
(P0). Presence of low number of GABA-IR cells at this growth
stage correlated with the in vitro GABA HPLC data (see below).
In order to promote and increase the proportion of cultured
cortical precursor cells to differentiate in vitro into GABAergic
phenotype, 5–10 days post-isolation neurosphereswere exposed to
0.1 ng/ml (low), 1 ng/ml (mid), or 10 ng/ml (standard concentra-
tion) of FGF-2 for 4–16 h (Figure 3). GABA-IR cells were observed
in all three conditions, and there were minimal difference between
4 and 16 h exposure in increasing the number of GABA-IR cells.
Neurospheres exposed to 0.1 ng/ml FGF-2 contained the highest
number of mature-looking GABA-IR cells (Figures 3A,B,D). The
inhibitory interneurons were mostly found inside neurospheres
tightly packed as a cluster composed almost entirely of GABA-
IR cells. Individual GABA-IR neuron possessed small and large
processes extending radially aroundandout from theneurosphere.
Axonal bouton enlargements were observed in processes of some
cells. Neurospheres exposed to 1 and 10 ng/ml FGF-2 did not
contain as many GABA-IR cells within the neurospheres as the
previous group. In these groups, most of the GABA-IR cells were
observed outside the neurospheres, as a single cell, in a migratory
pattern dispersing radially outward from the core of neurospheres.
These cells possessed short bipolar ormultipolar outgrowths from
the soma (Figures 3C,D). The predifferentiated neurospheres con-
tained numerous dividing cells indicated by presence of BrdU-IR
(Figure 3E). At this stage none of GABA-IRNPCs colocalized with
BrdU-IR, suggesting that these are pre-existing GABA cells.
IN VITRO ANALYSIS OF FGF-2 PREDIFFERENTIATED NEUROSPHERES
Several markers for mature and immature cell types were used
to identify different phenotypes present in the predifferentiated
neurospheres (Figure 4). A large proportion of NPCs expressed
GAD65/67-IR where a subpopulation of them also expressed
GABA-IR (Figure 4A). Many of GAD65/67-IR NPCs also colo-
calized with NeuN-IR (Figure 4B). Most of the embryonic prog-
enitor cells labeled positive for nestin-IR irrespective of FGF-2
pre-differentiation conditions (Figure 4C). These NPCs possessed
long elongated bipolar projections without any ﬁne dendritic
branches coming off from main projections. Large proportions
of nestin-IR cells were positively double labeled with GABA
(Figure 4C), but only a very small subset of GABA-IR NPCs
positively colocalized with NeuN (Figure 4D), indicating pres-
ence of immature GABAergic NPCs in the neurospheres. Beta-
III-tubulin-IR was observed in the NPCs, but only very small
number of them coexpressed GABA-IR (Figure 4E).ManyGABA-
IR NPCs colocalized with MAP-2, a marker for neural maturation
(Figure 4F). GFAP-IR was almost not present in the neurospheres
(data not shown).
IN VITRO QUANTITATION OF GABA RELEASE FROM
PREDIFFERENTIATED EMBRYONIC PRECURSOR CELLS
The level of spontaneously released GABA concentration in the
culture media was measured daily for 7 days using HPLC. Estab-
lishment of GABA release was critical to prove functional prop-
erties of our predifferentiated NPCs. The GABA concentrations
from originally harvested (P0) and in vitro cultured (P1) neu-
rospheres were measured. There were increased detectable levels
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FIGURE 3 | Brief exposure to varying concentrations of FGF-2 induces
differentiation of embryonic cortical progenitor cells into GABAergic
phenotype in cultured neurospheres. Progenitor cells exposed to low
concentration of FGF-2 expressed the largest number of GABA-IR cell
(A,B). Majority of these cells were found in or adjacent to the neurospheres
and did not show migratory pattern. Progenitor cells exposed to 1 or
10 ng/ml FGF-2 did not display as many GABA-IR cells as those exposed to
0.1 ng/ml. These GABA-IR cells were found predominantly outside the
neurospheres radiating outwardly in a migratory pattern (C,D). Large
proportion of NPCs can be labeled with BrdU, however, the GABA-IR cells
did not co-label with BrdU (E). A high magniﬁcation light microscopy image
of GABA-IR cells inside a neurosphere labeled with DAB peroxidase
reaction (F). Scale bars= 20μm (A); 50μm (B–E).
of GABA present in the culture media starting from day 1until the
last sample taken at day 7 post-isolation. For P0 cells, the GABA
concentration in themedia changed very little over time (Table 2).
Majority of P0 neurospheres did not survive more than 4 days
in vitro. The GABA concentrations from P0 cells at day 1 and day 4
were 0.3955 and 0.5609μM/20μl, respectively. On the other hand,
there was a dramatic increase in GABA concentration present in
the media of P1 neurospheres. Their initial GABA concentration
was very low (day 1= 0.0941μM/20μl) but increased by 10-fold
at day 7 (1.0673μM/20μl) suggesting massive differentiation of
NPCs into GABAergic cells.
CHANGES IN OVERGROOMING AREA FOLLOWING TRANSPLANTATION
OF GABAERGIC PRECURSOR CELLS
ExcitotoxicQUIS lesion caused a continuous andprogressive dam-
age to the spinal cord where the extent of the SCI as well as
the size of peripheral overgrooming area increased progressively
over time (Brewer and Yezierski, 1998). All of QUIS-lesioned
animals that received transplantation of control cells (bovine
FIGURE 4 | Predifferentiated embryonic precursor neurospheres
expressed robust immunoreactivity for GABA and other marker for
cell differentiation 5–7 days after harvest. (A) Many of GABA-IR NPCs
colocalized with GAD65/67-IR cells (arrows). (B) Majority of
predifferentiated GAD65/67-IR NPCs also expressed NeuN-IR. (C) Majority
of predifferentiated GABA-IR NPCs also expressed nestin-IR; Not every
nestin-IR cells expressed GABA-IR. Many GABA-IR cells colocalized and
expressed NeuN-IR (D), β-III-tubulin-IR (E), and MAP-2-IR (F).
adrenal ﬁbroblast, n = 7) showed a signiﬁcant increase in over-
grooming area over time where the area at pretransplantation
(baseline) was 130.2± 28.9mm2 and increased by three folds to
348.1± 115.08mm2 at 1week post-transplantation (Figures 5A,C
and 6A). By 2 and 3 weeks, the overgrooming area remained
signiﬁcantly enlarged to 438.5+ 121.0 and 399.0+ 120.80mm2,
respectively (p< 0.05). On the other hand, QUIS-lesioned ani-
mals that received transplantation of predifferentiated GABA-IR
NPCs (n = 27) did not show signiﬁcant increase in overgroom-
ing area, but remained at near baseline level during 3 weeks
of the testing period (Figures 5B,D). In these rats, the baseline
overgrooming areawas 181.5+ 27.3mm2, and 3weeks after trans-
plantation the overgrooming area remained at 237.3± 55.8mm2
(Figure 6A). Overall 55.6% of animals (n = 15/27) displayed
overgrooming areas that were either the same or smaller than
at pretransplantation stage; 27% of the animals (n = 7/27) dis-
played a 50% reduction in the overgrooming area by 3 weeks
post-transplantation. Seven animals completely recovered from
overgrooming injuries. When the percent changes in grooming
areas were compared between groups, the overgrooming areas
of rats that received GABA-IR NPCs were signiﬁcantly smaller
than ﬁbroblast-transplanted control rats during the experimental
period (p< 0.01; Figure 6B).
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FIGURE 5 | Photomicrographs showing changes in size of
overgrooming in QUIS animals transplanted with control bovine
fibroblast cells [pretransplantation: (A) 3 weeks post: (C)] and
predifferentiated GABA-IR NPCs [pretransplantation: (B), 3 weeks
post: (D)].
IDENTIFICATION OF GABA-IR NPCS IN THE SPINAL CORD OF
QUIS-LESIONED ANIMALS
Transplanted NPCs were observed within the spinal level of
QUIS-lesioned sites. The immunohistochemical analysis revealed
the NPCs were placed adjacent to the midline encompassing
the medial aspect of spinal gray matter and the dorsal column
(Figure 7). Surviving GABA-IR NPCs were observed covering a
large extent of the dorsal horn from Rexed’s lamina I–VI and as
medial as the dorsal column. Based on our previous study (Fur-
manski et al., 2009), the grafted cells were distinguished from
endogenous GABAergic interneurons by their different morphol-
ogy and location in the spinal cord. Grafted NPCs appeared
as large and round cells in superﬁcial and deeper dorsal horn
laminae in contrast to much smaller and elongated endogenous
interneurons located mainly in superﬁcial laminae. Overall, the
spinal cords could be divided into three groups: those contain-
ing (i) large, (ii) moderate, or (iii) minimal number of GABA-
IR NPCs in the dorsal gray matter. The number of surviving
GABA-IR NPCs inversely correlated with the size of overgroom-
ing area. Animals with large number of GABA-IR NPCs in the
spinal cord displayed the smallest to no overgrooming lesion
area. Animals containing medium to low number of GABA-IR
NPCs displayed same or increased overgrooming area compared
to pretransplantation state.
Overall, the spinal cords could be divided into three groups:
those containing (i) large, (ii) moderate, or (iii) minimal num-
ber of GABA-IR NPCs in the dorsal gray matter. The number
of surviving GABA-IR NPCs inversely correlated with the size
of overgrooming area. Animals with large number of GABA-IR
NPCs in the spinal cord displayed the smallest to no overgroom-
ing lesion area. Animals containing medium to low number of
GABA-IR NPCs displayed same or increased overgrooming area
compared to pretransplantation state.
FIGURE 6 | Percent change of the overgrooming area from
pretransplantation for GABA and fibroblast-transplanted rats. Control
animals displayed signiﬁcant increases in total overgrooming area (A) and
percent change of overgrooming area (B) post-transplantation vs.
pretransplantation and also compared to GABA-transplanted animals.
GABA-transplanted rats did not display statistically signiﬁcant changes in
either total or percent change of overgrooming compared to
pretransplantation. *p< 0.05 vs. pretransplantation, #p< 0.05 vs. GABA
group.
IN VIVO DIFFERENTIATION OF EMBRYONIC GABA-IR NPCs
Surviving NPCs within the injured spinal cord exhibited
immunoreactivity for GABA and several other cell markers. The
GABA-IR cells ranged in size of a small interneuron to a large
spinal motor neuron (Figure 8 left two columns). The GABA-IR
cells double labeled with neuronal marker, NeuN (Figures 8A–D),
but did not express nestin-IR indicating differentiation into
mature neurons. Although GFAP- and β-III-tubulin-IR were
present within the transplantation site of NPCs, neither of them
colocalized with GABA-IR (Figures 8I–P).
STEREOLOGICAL QUANTITATION OF GABA-IR CELLS IN THE QUIS
SPINAL CORD
Stereological evaluation was performed on spinal cord sections
from these animals in a tissue volume of 0.7± 0.04mm3. About
30–40% of surviving predifferentiated GABA-IR cells colocal-
ized with NeuN indicating maturity to neuronal phenotype
(Table 1). Themajority of GABA-IR cells (67.8± 2.7%)within the
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FIGURE 7 |Transplanted predifferentiated GABA-IR NPCs were visible in
the spinal cord of QUIS animals three weeks after transplantation, and
showed varying densities in the host spinal cord. Animals that stopped
overgrooming [healed; (A,B)] or displayed reduction in overgrooming (C,D)
exhibited large number of transplanted GABA-IR NPCs in the spinal gray
matter. Animals that continued to groom contained very few number of
surviving GABA-IR cells in the spinal cord (E,F). Scale bars= 500μm.
transplant area did not colocalize with NeuN indicating imma-
turity 3 weeks post-transplantation into host spinal cord. Sim-
ilar numbers were obtained when sections were processed for
GAD65/67 (data not shown).
DISCUSSION
Results from the present study show that intraspinal transplan-
tation of predifferentiated embryonic GABAergic NPCs, but not
bovine ﬁbroblast cells, signiﬁcantly decreases self-injurious over-
grooming lesions observed in QUIS injured rats. The decrease in
overgrooming may be mediated by the GABA released from the
transplanted precursor cells since the reduction in grooming was
observed primarily GABA-transplated QUIS animals. Manifesta-
tion of overgrooming behavior is thought to have a relation with
dysesthetic and nociceptive sensations since subdural transplanta-
tion of analgesic compound-releasing chromafﬁn cells can reverse
mechanical and thermal nociceptive thresholds in QUIS rats, in
addition to signiﬁcant reduction on the size of overgrooming area
by 2 weeks post-transplantation compared to muscle transplanted
control rats (Brewer and Yezierski, 1998).
In our experiment, reversal of overgrooming lesion was
observed in 55.6% (n = 15/27) of GABA-transplanted rats from
which seven rats recovered completely from self-inﬂicted der-
mal injuries 3 weeks post-transplantation. The main contributing
factor for these recoveries may be the secretion of GABA in the
lesioned dorsal horn by the embryonic GABA-IR NPCs trans-
planted into the host spinal cord, since ﬁbroblast-transplanted
control rats (n = 7) or QUIS animals with only a small number of
surviving transplantedGABA cells did not show a decrease in their
overgrooming lesion. In fact, the latter group of animals showed
increasing overgrooming lesion size overtime closely resembling
the pattern observed in ﬁbroblast-transplanted control rats. The
results from our experiment show intraspinal transplantation of
GABA secreting embryonic precursor cells are effective in reduc-
ing centrally- and peripherally mediated nociceptive behaviors
without causing sensory and motor deﬁcits, similar to observa-
tions reported by others (Hendricks et al., 2006; Mukhida et al.,
2007; Wolfe et al., 2007).
Changes in the number and expression of endogenous GABA
leading to abnormal inhibitory signaling following spinal or
peripheral nerve injuries have been well documented in several
rodents pain models, yet their role in expression of nociceptive
behaviors remain divided (Polgar et al., 2003; Lee et al., 2008; Pol-
gar and Todd, 2008; Meisner et al., 2010). The postulated loss of
GABAergic neurons is controversial, however, as a reduction in
GABAergic immunoreactivity in parallel with the development
of neuropathic pain symptoms is not always observed (Polgar
et al., 2003, 2004; Polgar and Todd, 2008). Nevertheless, alter-
native explanations for disinhibition after nerve injury include
reduced GABA synthesis in existing intact, but dysfunctional
neurons or reduced excitatory drive to GABAergic dorsal horn
neurons following loss of primary afferent input to these cells.
Alterations in GABA receptors, e.g., loss of receptors or reversion
to a neonatal excitatory and pronociceptive GABA phenotypemay
also occur. Diminished GABAergic inhibitory effects via reduced
expression of the potassium co-transporter KCC-2 and disrup-
tion of the chloride gradient has been suggested as an underlying
mechanism of activated microglia in neuropathic pain induction
(Coull et al., 2003, 2005). However, pharmacologic ﬁndings argue
against a complete excitatory reversion since GABA and GABAer-
gic agonists can reduce neuropathic pain behaviors. In addition,
electrophysiological studies suggest that diminishedGABA release,
rather than changes in receptor density, account for the loss in
GABAergic inhibition in peripheral nerve injury models (Moore
et al., 2002). Regardless whether or not overt GABAergic cellular
death occurs, it is clear that loss of spinal inhibitory tone and con-
sequent abnormal hyperexcitability contribute to themaintenance
of neuropathic pain, and is a promising target for intervention.
Previously, our group reported selective loss of endoge-
nous GABA-IR cells following excitotoxic QUIS lesion in rats
(Lee et al., 2008), similar to the previously mentioned animal
pain/nociceptive models that reported loss of GABAergic cells.
It is not clear whether the decrease of GABA-labeled cells is due
to apoptosis, down-regulation of GAD genes, or another mech-
anism. Spinal contusion injury-induced secretion of excitatory
amino acids and subsequent activation of metabotropic glutamate
receptors (mGluRs) has been shown to increase theGABA concen-
tration in the spinal cord by 160% (4.8μM) within half an hour
of injury (Mills et al., 2001). Blocking mGluR1/5 with antago-
nist agents (10 nMAIDA, LY 367385+MPEP) can prevent GABA
release. It is possible that excessive mGluR1/5 activity after SCI
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FIGURE 8 | Photomicrographs of QUIS spinal cord transplanted with
GABA-IR NPCs.The NPCs were double labeled with NeuN (A–D), nestin
(E–H), GFAP (I–L), and β-III-tubulin (M–P). Medium (A,E,I,M) and high
magniﬁcation (B,F,J,N) of QUIS spinal cord stained for GABA-IR NPCs. The
dotted lines represent the spinal gray matter, and white boxes represent the
ROI in panels (B,F,J,N). Majority of GABA-IR NPCs double labeled with
NeuN-IR (B–D). However, the GABA-IR NPCs did not colocalize with nestin
(F–H), GFAP (J–L), or with β-III-tubulin (N–P).
Table 1 | Stereological quantitation of predifferentiated GABAergic precursor cells following intraspinal transplantation of QUIS animals.
ID GABA only
(single)
GABA+NeuN
(double)
GABA total % of GABA only % of GABA+NeuN Total counting
area (μm2)
Total volume (mm3)
Q12 606 401 1007 60 40 4350 0.74
Q16 952 422 1374 69 31 3600 0.61
Q24 314 137 451 70 30 3600 0.61
Q26 536 204 740 72 28 4350 0.74
could contribute to depletion of cellular GABA stores, indicated
by decreased GABA immunoreactivity. We also provide evidence
that glycine is reduced similar to GABA in the injured dorsal horn.
Since GABA and glycine are frequently co-released at synapses,
in part due to the shared vesicular transporter VIAAT (Wojcik
et al., 2006; Juge et al., 2009), excessive mGluR1/5 activity could
contribute to depletion of glycine stores as well.
The VIAAT loads GABA and glycine into presynaptic vesi-
cles at inhibitory synapses (Dumoulin et al., 1999). In the cur-
rent experiments, we found that VIAAT-IR was decreased in
the QUIS-lesioned dorsal horn. Furthermore, colocalization of
GABA, VIAAT, and the synaptic protein synaptobrevin was sub-
stantially decreased in the injured dorsal horn. An injury-induced
decrease in VIAAT expression could lead to an inability to load
available GABA into presynaptic vesicles, which could be reﬂected
by increased free GABA-IR in the injured dorsal horn. Another
possible mechanism is that QUIS-induced cell death in the dorsal
horn deprives inhibitory neurons of their targets, causing axonal
retraction, and decreased axonal trafﬁcking of inhibitory vesi-
cles. Alone or in combination, these potential causes of decreased
inhibitory synaptic communication could operate in concert with
previously described mechanisms of spinal cord hyperexcitability
that are associated with injury-induced chronic pain.
Embryonic stem and precursor cells can be grown in culture
and, depending on growth factors, can be induced to differentiate
into many different cell types. In this study, we explored ways to
promote and increase the number of cultured cortical precursor
cells to differentiate in vitro into GABAergic phenotype by varying
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Table 2 | Non-stimulation-induced released GABA concentration in the N2 growth media over time for P0 and P1 embryonic precursor cells
(μM/20μl).
Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7
Passage 0 0.3955 0.3187 0.3844 0.5609 N/A N/A N/A
Passage 1 0.0941 0.0993 0.1540 0.2088 0.6500 0.9475 1.0673
the concentration level of FGF-2present in the growthmedia.Cells
grown under standard concentration of FGF-2 then switched to
low concentration (0.1 ng/ml) for several hours facilitated trans-
formation to GABAergic phenotype. The molecular biochemistry
underlying such transformation remains unclear. It is important
to note that not all phenotypic GABA cells colocalized with the
neuronal marker NeuN. The vast majority of GABAergic cells
colocalized with β-III-tubulin and MAP-2 suggesting incomplete
neuronal differentiation 24–36 h after FGF-2 removal.
In addition to GABA, the vast majority of NPCs in these cul-
tures were nestin-IR, indicating they were undifferentiated prog-
enitor cells. All GABA-positive cells were double labeled with
nestin. But no GABA cells colocalized with GFAP-IR cells indicat-
ing that most of our GABA cells were still in immature state and
GABA was not present in the astrocytes. The majority of GABA
cells were found as a cluster inside the neurospheres, suggesting
they are clonally derived. Functional biochemical properties of
ourGABAergic neurosphereswere demonstrated by high-pressure
liquid chromatography (HPLC) where the secreted/released con-
centration of GABA in the culture media increased 10-fold to
1μM/20μl culture media over a 7-day period in vitro (Table 2).
We were not able to obtain in vitro GABA HPLC data for P0 cells
beyond 4 days due to decreased representation of GABA neurons
in the culture with time (data not shown). Only the P0 precur-
sor cells proliferate in the N2 culture media while the P0 GABA
cells do not. Therefore in the non-proliferating P0 GABA cells
that are already differentiated cells become a negligible fraction by
day 4. In contrast the large numbers of P1 precursors differentiate
into GABAergic cells persist longer in the culture in the absence
of any cell proliferation. These data demonstrate that brief expo-
sure of embryonic cortical precursor cells to low concentration
of FGF-2 stimulates GABAergic cell differentiation, but that the
differentiation status remains largely incomplete.
Overgrooming behavior observed in QUIS rats is thought to
have a nociceptive component in its expression. Previously, sub-
dural transplantation of chromafﬁn cells in the spinal cord of
QUIS animals signiﬁcantly decreased their overgrooming area
directly demonstrating analgesic compound secreted from chro-
mafﬁn cells,mainly norepinephrine, can reduce the overgrooming
behavior (Brewer and Yezierski, 1998). In the present experi-
ment, intraspinal transplantation of predifferentiated embryonic
GABAergic cells also signiﬁcantly decreased theovergrooming area
at all-time points studied compared to ﬁbroblast-transplanted
control QUIS rats. The main factor for such an effect was most
likely the absence of GABA cells since QUIS animals with very
few surviving GABA cells also showed increased overgrooming.
We know from past reports that only about 5–10% of transplants
survive following incorporation to the host CNS (Chow et al.,
2000; Cao et al., 2002; Hendricks et al., 2006; Lepore et al., 2006)
but this number is sufﬁcient for producing a signiﬁcant effect on
host behavior. Our recent paper (Jergova et al., 2012) shows that
intraspinal injection of GABAergic progenitors partially restore
inhibitory tone in the spinal cord in CCI model. Behavioral and
electrophysiological experiments showed that the analgesic effect
of grafted cell is positively or negatively modulated by GABA
reuptake inhibitor or GABA receptor antagonist respectively.
In present study, quantitation of surviving GABAergic cells
from select tissues showed that over 67% of transplanted cells
remained as incompletely differentiated GABAergic cells. How-
ever, about 40% of predifferentiated cells displayed neuronal
phenotypes positive for NeuN immunoreactivity.
Several reports exist that describe transplantations of predif-
ferentiated GABAergic and non-GABAergic embryonic precursor
cells to alleviate peripheral and central neuropathic pain (Eaton
et al., 1999b; Stubley et al., 2001; Hendricks et al., 2006; Mukhida
et al., 2007; Jergova et al., 2012). However, the present study is ﬁrst
to describe the effect of predifferentiated embryonic GABAergic
cells transplanted in SCI animals to reverse dysesthetic/nociceptive
behaviors.
In summary, the current study suggests transplantationof pred-
ifferentiated embryonicGABAergic cells inQUIS-lesioned rats can
greatly reduce the overgrooming lesion size. Such reduction may
bemediated with the release of GABA from the transplants. GABA
replacement therapy through cell transplantation could be used
to offset losses of inhibitory signaling molecules in injured spinal
cord graymatter. The reversal of overgrooming behavior was asso-
ciated with the density of surviving GABA-IR transplants in the
injured host spinal cord.
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